Development of Genistein Synthesis for Use as a Certified Reference Material

Introduction. The use of certified reference materials (CRMs) ensures metrological traceability and comparability of analysis results performed in different laboratories, by different analysts, at different times. Genistein is a promising substance with a wide spectrum of pharmacological action. gen...

Full description

Bibliographic Details
Main Authors: A. A. Zhigalina, V. G. Dudarev, V. V. Tikhonova, O. Yu. Strelova
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2021-12-01
Series:Разработка и регистрация лекарственных средств
Subjects:
Online Access:https://www.pharmjournal.ru/jour/article/view/1097
_version_ 1826569709548470272
author A. A. Zhigalina
V. G. Dudarev
V. V. Tikhonova
O. Yu. Strelova
author_facet A. A. Zhigalina
V. G. Dudarev
V. V. Tikhonova
O. Yu. Strelova
author_sort A. A. Zhigalina
collection DOAJ
description Introduction. The use of certified reference materials (CRMs) ensures metrological traceability and comparability of analysis results performed in different laboratories, by different analysts, at different times. Genistein is a promising substance with a wide spectrum of pharmacological action. genistein is widely used in dietary supplements. Development of regulatory documents for CRM of genistein will ensure the quality of drugs and dietary supplements.Aim. Aim of our study is to improve of the ways of synthesis and determination of spectrum characteristics of genistein for the certification of CRM.Materials and methods. We used synthetic genistein, (Ph.D. V. Yu. Kovtun SPC "Pharmzashchita") (sample № 1) and genistein synthesized and studied at the departments of pharmaceutical chemistry and chemical technology of medicinal substances SPCPU (sample № 2). Infrared spectra of genistein samples were collected on an FSM 1201 infrared Fourier spectrometer (OOO Infraspek, Russia) via KBr pellets technique. All the spectra were collected in the 4000–500 cm−1 range. The NMR (1H and 13C) measurements were performed with a BrukerAvance III NMR spectrometer (400 and 100 MHz) (Bruker, Germany) in DMSO-d6 solvent. Raman spectra were recorded by an ORTES-785TRS-2700 analytical Raman scattering system at a laser power of 100 mW (OPTEC JSC, Russia). Laser interaction time was 5, 10, 20 and 60 seconds. The results were processed using the software "BWSpec 4.10_4", USA. GC-MS was performed on an Agilent Technologies 7890A gas chromatograph (Agilent Technologies, USA) with a 7693 autoinjector and a Hewlett Packard 5975C mass selective detector.Results and discussion. The synthesis was carried out according to the developer's method. The stage "removal of the alkyl protection" has been improved. The spectra of the synthesis intermediate of genistein (biochanin A) correspond to the literature data. Samples of genistein were investigated by methods: MC and NMR 13С, 1Н. The structure of the investigated substance was confirmed; Raman and IR spectroscopy showed that the spectra of the samples do not differ from each other and there are no additional signals.Conclusion. The spectrum characteristics of samples of genistein were obtained by NMR, IR and Raman spectroscopy, which will be used in the regulatory documentation for CRM of genistein. All of this will make it possible to control the quality of medicines based on it and to identify substandard dietary supplements.
first_indexed 2024-04-10T01:39:36Z
format Article
id doaj.art-ccd42ca98eb64e04a6fd967da477a94b
institution Directory Open Access Journal
issn 2305-2066
2658-5049
language Russian
last_indexed 2025-03-14T11:43:39Z
publishDate 2021-12-01
publisher LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
record_format Article
series Разработка и регистрация лекарственных средств
spelling doaj.art-ccd42ca98eb64e04a6fd967da477a94b2025-03-02T09:53:25ZrusLLC Center of Pharmaceutical Analytics (LLC «CPHA»)Разработка и регистрация лекарственных средств2305-20662658-50492021-12-01104203110.33380/2305-2066-2021-10-4(1)-20-31904Development of Genistein Synthesis for Use as a Certified Reference MaterialA. A. Zhigalina0V. G. Dudarev1V. V. Tikhonova2O. Yu. Strelova3Saint-Petersburg State Chemical-Pharmaceutical UniversitySaint-Petersburg State Chemical-Pharmaceutical UniversitySaint-Petersburg State Chemical-Pharmaceutical UniversitySaint-Petersburg State Chemical-Pharmaceutical UniversityIntroduction. The use of certified reference materials (CRMs) ensures metrological traceability and comparability of analysis results performed in different laboratories, by different analysts, at different times. Genistein is a promising substance with a wide spectrum of pharmacological action. genistein is widely used in dietary supplements. Development of regulatory documents for CRM of genistein will ensure the quality of drugs and dietary supplements.Aim. Aim of our study is to improve of the ways of synthesis and determination of spectrum characteristics of genistein for the certification of CRM.Materials and methods. We used synthetic genistein, (Ph.D. V. Yu. Kovtun SPC "Pharmzashchita") (sample № 1) and genistein synthesized and studied at the departments of pharmaceutical chemistry and chemical technology of medicinal substances SPCPU (sample № 2). Infrared spectra of genistein samples were collected on an FSM 1201 infrared Fourier spectrometer (OOO Infraspek, Russia) via KBr pellets technique. All the spectra were collected in the 4000–500 cm−1 range. The NMR (1H and 13C) measurements were performed with a BrukerAvance III NMR spectrometer (400 and 100 MHz) (Bruker, Germany) in DMSO-d6 solvent. Raman spectra were recorded by an ORTES-785TRS-2700 analytical Raman scattering system at a laser power of 100 mW (OPTEC JSC, Russia). Laser interaction time was 5, 10, 20 and 60 seconds. The results were processed using the software "BWSpec 4.10_4", USA. GC-MS was performed on an Agilent Technologies 7890A gas chromatograph (Agilent Technologies, USA) with a 7693 autoinjector and a Hewlett Packard 5975C mass selective detector.Results and discussion. The synthesis was carried out according to the developer's method. The stage "removal of the alkyl protection" has been improved. The spectra of the synthesis intermediate of genistein (biochanin A) correspond to the literature data. Samples of genistein were investigated by methods: MC and NMR 13С, 1Н. The structure of the investigated substance was confirmed; Raman and IR spectroscopy showed that the spectra of the samples do not differ from each other and there are no additional signals.Conclusion. The spectrum characteristics of samples of genistein were obtained by NMR, IR and Raman spectroscopy, which will be used in the regulatory documentation for CRM of genistein. All of this will make it possible to control the quality of medicines based on it and to identify substandard dietary supplements.https://www.pharmjournal.ru/jour/article/view/1097genisteincrmnmrirraman spectroscopy
spellingShingle A. A. Zhigalina
V. G. Dudarev
V. V. Tikhonova
O. Yu. Strelova
Development of Genistein Synthesis for Use as a Certified Reference Material
Разработка и регистрация лекарственных средств
genistein
crm
nmr
ir
raman spectroscopy
title Development of Genistein Synthesis for Use as a Certified Reference Material
title_full Development of Genistein Synthesis for Use as a Certified Reference Material
title_fullStr Development of Genistein Synthesis for Use as a Certified Reference Material
title_full_unstemmed Development of Genistein Synthesis for Use as a Certified Reference Material
title_short Development of Genistein Synthesis for Use as a Certified Reference Material
title_sort development of genistein synthesis for use as a certified reference material
topic genistein
crm
nmr
ir
raman spectroscopy
url https://www.pharmjournal.ru/jour/article/view/1097
work_keys_str_mv AT aazhigalina developmentofgenisteinsynthesisforuseasacertifiedreferencematerial
AT vgdudarev developmentofgenisteinsynthesisforuseasacertifiedreferencematerial
AT vvtikhonova developmentofgenisteinsynthesisforuseasacertifiedreferencematerial
AT oyustrelova developmentofgenisteinsynthesisforuseasacertifiedreferencematerial